89 related articles for article (PubMed ID: 12835724)
1. NF- kappa B2/p100 induces Bcl-2 expression.
Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville MP; Bours V
Leukemia; 2003 Jul; 17(7):1349-56. PubMed ID: 12835724
[TBL] [Abstract][Full Text] [Related]
2. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology.
Beinke S; Ley SC
Biochem J; 2004 Sep; 382(Pt 2):393-409. PubMed ID: 15214841
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
Nishikori M; Ohno H; Haga H; Uchiyama T
Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
[TBL] [Abstract][Full Text] [Related]
4. Structures of NF-κB p52 homodimer-DNA complexes rationalize binding mechanisms and transcription activation.
Pan W; Meshcheryakov VA; Li T; Wang Y; Ghosh G; Wang VY
Elife; 2023 Feb; 12():. PubMed ID: 36779700
[TBL] [Abstract][Full Text] [Related]
5. Critical and distinct roles of cell type-specific NF-κB2 in lung cancer.
Sun F; Xiao Y; Shapiro SD; Qu Z; Xiao G
JCI Insight; 2024 Feb; 9(4):. PubMed ID: 38385745
[TBL] [Abstract][Full Text] [Related]
6. Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene.
Potter DA; Larson CJ; Eckes P; Schmid RM; Nabel GJ; Verdine GL; Sharp PA
J Biol Chem; 1993 Sep; 268(25):18882-90. PubMed ID: 8360178
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors.
Schlein LJ; Thamm DH
Vet Pathol; 2024 Jan; 61(1):20-31. PubMed ID: 37357953
[TBL] [Abstract][Full Text] [Related]
8. Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52.
Li D; Dewey MG; Wang L; Falcinelli SD; Wong LM; Tang Y; Browne EP; Chen X; Archin NM; Margolis DM; Jiang G
iScience; 2022 Jan; 25(1):103649. PubMed ID: 35024584
[TBL] [Abstract][Full Text] [Related]
9. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
Mansouri L; Sutton LA; Ljungström V; Bondza S; Arngården L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sörqvist E; Lönn P; Muggen AF; Yan XJ; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellström M; Jernberg-Wiklund H; Ghia P; Söderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
J Exp Med; 2015 Jun; 212(6):833-43. PubMed ID: 25987724
[TBL] [Abstract][Full Text] [Related]
10. BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism.
Majid A; Tsoulakis O; Walewska R; Gesk S; Siebert R; Kennedy DB; Dyer MJ
Blood; 2008 Jan; 111(2):874-7. PubMed ID: 17959858
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling.
Turnham DJ; Smith H; Clarkson RWE
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255248
[TBL] [Abstract][Full Text] [Related]
12. Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications.
Sun J; Chen F; Wu G
Aging (Albany NY); 2023 Oct; 15(20):11313-11330. PubMed ID: 37847185
[TBL] [Abstract][Full Text] [Related]
13. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Geng C; Zhang MC; Manyam GC; Vykoukal JV; Fahrmann JF; Peng S; Wu C; Park S; Kondraganti S; Wang D; Robinson BD; Loda M; Barbieri CE; Yap TA; Corn PG; Hanash S; Broom BM; Pilié PG; Thompson TC
Clin Cancer Res; 2023 Nov; 29(21):4464-4478. PubMed ID: 37581614
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations.
Ahmadi Y; Fard JK; Ghafoor D; Eid AH; Sahebkar A
Cancer Cell Int; 2023 Mar; 23(1):43. PubMed ID: 36899388
[TBL] [Abstract][Full Text] [Related]
15. Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer.
Pan W; Deng L; Wang H; Wang VY
Front Cell Dev Biol; 2022; 10():930619. PubMed ID: 35990614
[TBL] [Abstract][Full Text] [Related]
16. LTβR overexpression promotes plasma cell accumulation.
Kotov JA; Xu Y; Carey ND; Cyster JG
PLoS One; 2022; 17(8):e0270907. PubMed ID: 35925983
[TBL] [Abstract][Full Text] [Related]
17. Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology.
Carr D; Zein A; Coulombe J; Jiang T; Cabrita MA; Ward G; Daneshmand M; Sau A; Pratt MAC
Breast Cancer Res; 2022 Jun; 24(1):40. PubMed ID: 35681213
[TBL] [Abstract][Full Text] [Related]
18. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.
Schmid F; Dahlmann M; Röhrich H; Kobelt D; Hoffmann J; Burock S; Walther W; Stein U
Br J Cancer; 2022 Sep; 127(4):675-685. PubMed ID: 35597866
[TBL] [Abstract][Full Text] [Related]
19. Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression.
Quijada-Álamo M; Hernández-Sánchez M; Rodríguez-Vicente AE; Pérez-Carretero C; Rodríguez-Sánchez A; Martín-Izquierdo M; Alonso-Pérez V; García-Tuñón I; Bastida JM; Vidal-Manceñido MJ; Galende J; Aguilar C; Queizán JA; González-Gascón Y Marín I; Hernández-Rivas JÁ; Benito R; Ordóñez JL; Hernández-Rivas JM
Blood Cancer J; 2021 Jul; 11(7):127. PubMed ID: 34244476
[TBL] [Abstract][Full Text] [Related]
20. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
